Florian Renosi

Besancon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Relationship Between Salvage Strategy and Outcomes in Patients With CBF or NPM1-mutated AML and First Molecular Relapse.

Relationship Between Salvage Strategy and Outcomes in Patients With CBF or NPM1-mutated AML and First Molecular Relapse.

Journal: Blood advances

Published: May 13, 2026

Mature plasmacytoid dendritic cell proliferations are also associated with T-cell acute lymphoblastic leukemia: towards an expanding range of associated neoplasms.

Mature plasmacytoid dendritic cell proliferations are also associated with T-cell acute lymphoblastic leukemia: towards an expanding range of associated neoplasms.

Journal: Haematologica

Published: May 04, 2026

A Subset of Pro-inflammatory CXCL10+ LILRB2+ Macrophages Derives From Recipient Monocytes and Drives Renal Allograft Rejection.

A Subset of Pro-inflammatory CXCL10+ LILRB2+ Macrophages Derives From Recipient Monocytes and Drives Renal Allograft Rejection.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 24, 2025

Contribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasms.

Contribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasms.

Journal: Annals of hematology

Published: July 30, 2025

Pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm: assessing spatial response and unraveling resistance mechanisms.

Pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm: assessing spatial response and unraveling resistance mechanisms.

Journal: Haematologica

Published: July 10, 2025

Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities.

Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities.

Journal: Molecular therapy. Oncology

Published: June 13, 2025

Venetoclax in the Therapeutic Strategy for BPDCN Management.

Venetoclax in the Therapeutic Strategy for BPDCN Management.

Journal: EJHaem

Published: January 09, 2025

New leads to enhance tagraxofusp efficacy in pDC-AML.

New leads to enhance tagraxofusp efficacy in pDC-AML.

Journal: Blood neoplasia

Published: October 28, 2024

Blastic Plasmocytoid Dendritic Cell Neoplasm With Pseudo-Lymphoid Morphology Mimicking Lymphoid Malignancy.

Blastic Plasmocytoid Dendritic Cell Neoplasm With Pseudo-Lymphoid Morphology Mimicking Lymphoid Malignancy.

Journal: American journal of hematology

Published: September 30, 2024

Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia - a FILO study.

Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia - a FILO study.

Journal: Leukemia

Published: April 03, 2024

Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.

Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.

Journal: Cancer immunology research

Published: July 10, 2023

Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells.

Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells.

Journal: Cancers

Published: June 30, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026